Coherus Oncology, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Coherus Oncology, Inc. (CHRS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.60 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-05
- Coherus Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.60M, a 51.49% decline year-over-year.
- Coherus Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $2.41M, a 54.90% decline year-over-year.
- Coherus Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $3.40M, a 50.66% decline year-over-year.
- Coherus Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $5.36M, a 26.87% decline year-over-year.
- Coherus Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $16.91M, a 40.36% decline from fiscal 2024.
- Coherus Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $28.35M.
- Coherus Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $51.19M, a 0.20% decline from fiscal 2021.
- Coherus Oncology, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $51.29M, a 31.38% increase from fiscal 2020.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.60M 10-Q · filed 2026-08-05 | $5.01M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $2.41M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $16.91M 10-K · filed 2026-03-09 | |||
| 2025-09-30 | $3.40M 10-Q · filed 2025-11-06 | $8.76M derived: sum of 2 quarters · filed 2026-08-05 | $14.12M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $5.36M 10-Q · filed 2026-08-05 | $10.71M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $5.35M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $28.35M 10-K · filed 2026-03-09 | |||
| 2024-09-30 | $6.90M 10-Q · filed 2025-11-06 | $14.23M derived: sum of 2 quarters · filed 2025-11-06 | $21.90M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $7.33M 10-Q · filed 2025-11-06 | $15.00M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $7.68M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $43.54M 8-K · filed 2025-11-13 | |||
| 2023-09-30 | $10.15M 10-Q · filed 2024-11-06 | $20.19M derived: sum of 2 quarters · filed 2024-11-06 | $32.47M derived: sum of 3 quarters · filed 2024-11-06 | |
| 2023-06-30 | $10.03M 10-Q · filed 2024-11-06 | $22.32M derived: sum of 2 quarters · filed 2024-11-06 | ||
| 2023-03-31 | $12.29M 10-Q · filed 2024-11-06 | |||
| 2022-12-31 | $51.19M 10-K · filed 2025-03-17 | |||
| 2022-09-30 | $12.39M 10-Q · filed 2023-11-06 | $26.32M derived: sum of 2 quarters · filed 2023-11-06 | $39.36M derived: sum of 3 quarters · filed 2023-11-06 | |
| 2022-06-30 | $13.94M 10-Q · filed 2023-11-06 | $26.97M derived: sum of 2 quarters · filed 2023-11-06 | ||
| 2022-03-31 | $13.04M 10-Q · filed 2023-11-06 | |||
| 2021-12-31 | $51.29M 10-K · filed 2024-03-15 | |||
| 2021-09-30 | $11.79M 10-Q · filed 2022-11-08 | $23.30M derived: sum of 2 quarters · filed 2022-11-08 | $40.28M derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $11.51M 10-Q · filed 2022-11-08 | $28.49M derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | $16.98M 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $39.04M 10-K · filed 2023-03-06 | |||
| 2020-09-30 | $9.46M 10-Q · filed 2021-11-08 | $19.14M derived: sum of 2 quarters · filed 2021-11-08 | $29.09M derived: sum of 3 quarters · filed 2021-11-08 | |
| 2020-06-30 | $9.69M 10-Q · filed 2021-11-08 | $19.63M derived: sum of 2 quarters · filed 2021-11-08 | ||
| 2020-03-31 | $9.95M 10-Q · filed 2021-11-08 | |||
| 2019-12-31 | $35.22M 10-K · filed 2022-02-23 | |||
| 2019-09-30 | $9.20M 10-Q · filed 2019-11-08 | $17.70M derived: sum of 2 quarters · filed 2019-11-08 | $27.52M derived: sum of 3 quarters · filed 2019-11-08 | |
| 2019-06-30 | $8.50M 10-Q · filed 2019-11-08 | $18.32M derived: sum of 2 quarters · filed 2019-11-08 | ||
| 2019-03-31 | $9.81M 10-Q · filed 2019-11-08 | |||
| 2018-12-31 | $34.98M 10-K · filed 2021-02-25 | |||
| 2018-09-30 | $8.56M 10-Q · filed 2019-11-08 | $17.25M derived: sum of 2 quarters · filed 2019-11-08 | $25.97M derived: sum of 3 quarters · filed 2019-11-08 | |
| 2018-06-30 | $8.69M 10-Q · filed 2019-11-08 | $17.41M derived: sum of 2 quarters · filed 2019-11-08 | ||
| 2018-03-31 | $8.72M 10-Q · filed 2019-11-08 | |||
| 2017-12-31 | $33.40M 10-K · filed 2020-02-27 | |||
| 2016-12-31 | $27.42M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $16.71M 10-K · filed 2018-03-08 | |||
| 2014-12-31 | $11.12M 10-K · filed 2017-03-14 | |||
| 2013-12-31 | $2.04M 10-K · filed 2016-02-29 | |||
| 2012-12-31 | $443.00K 10-K · filed 2015-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |